Refinitiv assesses firms based on their industry, and the company’s ESG score is low.
Strengths:
Strengths: The analysts’ current projection for profits growth in the upcoming years is quite robust.
Considering its net cash and margin position, the corporation is in a strong financial position.
● The stock is obviously overpriced when compared to peers, with a current market value of 2024 to 0.65 times its sales.
● The firm is reasonably priced as compared to its net book value, as shown by the share price.
● With strong dividend expectations, the firm is among the finest yielding stocks.
Weaknesses:
● Standard & Poor’s projection indicates that revenue growth prospects for the upcoming fiscal years are projected to be quite low.
● Sales forecasts have been sharply lowered during the last 12 months, indicating that lower-than-expected sales volumes are anticipated for the current fiscal year compared to the prior one.
● The corporation has downgraded its sales projections for the upcoming years, indicating a potential downturn in commercial activity.
● Analysts have considerably revised lower their earnings projections over the past year.
● Over the last four months, the consensus view among experts has drastically declined.
● The analysts’ consensus has been sharply revised lower during the last 12 months.
● The stock’s analysts’ predictions are inconsistent. Such disparate revenue projections attest to the limited understanding of the group’s operations.
● There are notable differences in the price goals set by analysts covering the stock. This suggests that assessing the corporation and its operations may be challenging.